Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Rewiring local immune milieu by boosting dendritic cell for pancreatic cancer treatment
Hyperthermia treatment advances for brain tumors
Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model
Oncolytic Viral Therapy for Malignant Pleural Mesothelioma
Oncolytic therapy and gene therapy for cancer: recent advances in antitumor effects of Newcastle disease virus
Position paper: new insights into the immunobiology and dynamics of tumor-host interactions require adaptations of clinical studies
State-of-the-art exosome loading and functionalization techniques for enhanced therapeutics: a review
Cytotoxicity study of the interleukin-12-expressing recombinant Newcastle disease virus strain, rAF-IL12, towards CT26 colon cancer cells in vitro and in vivo
Newcastle disease virus suppress glycolysis pathway and induce breast cancer cells death
CD133 mRNA-Loaded Dendritic Cell Vaccination Abrogates Glioma Stem Cell Propagation in Humanized Glioblastoma Mouse Model
Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccine
Silencing adenosine A2a receptor enhances dendritic cell-based cancer immunotherapy
Integrating Loco-Regional Hyperthermia Into the Current Oncology Practice: SWOT and TOWS Analyses
Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion
IOZK Analyse belegt gute Verträglichkeit der IOZK Immuntherapie beim Diffusen intrinsischen pontinen Gliom (DIPG)
Relationship between Energy Dosage and Apoptotic Cell Death by Modulated Electro-Hyperthermia
Dendritic cell vaccine as an alternative to opioid analgesia in patients with advanced cervical cancer.
Dendritic Cell-Based Therapy Using LY6E Peptide with a Putative Role Against Colorectal Cancer
Dendritic Cells and Their Role in Immunotherapy
Addition of Multimodal Immunotherapy to Combination Treatment Strategies for Children with DIPG: A Single Institution Experience